EPHA1 and non-small cell lung carcinoma: TAZ-AS202 enhances aggressive properties of NSCLC cell lines, such as migration and invasion, by regulating a set of genes belonging to cancer-associated pathways, including WNT and EPH-Ephrin signaling.